pretickt

Is VTR a good stock to buy?

Ventas, Inc. · end-of-day data as of Nov 13, 2026

Ventas
VTR · $47.02B
$88.92-0.8%
Nov 13, 2026 · close
$80$85$90SepOctNov9:3016:003 months -1.9%Nov 13 · close
▲ 5
  • PT$97.37 +9.5%
  • ConsensusBuy · 24
  • MAs3 of 4
  • MA20×50Golden 2d ago
  • MACD0.42
Neutral
  • Earnings in83d
  • P/E167.8x
  • RSI56
  • Support-3.8%
  • Resistance+1.1%
  • Off 52w high-12.5%
  • Volume0.6x
  • Bollingerupper half
  • News0.00
  • P/E vs own+9.3%
  • Trendsideways
  • Sector→ -1.7%
  • 52w range$74–$102
  • ATR+2.4%
  • Off ATH-12.5%
  • InsidersNone in 90d
▼ 1
  • P/E vs sector+449.0%

Updates with the 15-min delayed price. Not a forecast or investment advice.

Is Ventas a good stock to buy?

Ventas is strong on 3 of the 4 questions about the business. The price is about usual: 167.8 times its earnings, near its 3-year median of 162.4 (Nov 13, 2026). pretickt does not say whether to buy or sell.

  1. Demand growing
  2. Advantage some edge
  3. Economics profits growing
  4. Execution no reading
  5. Fragility sturdy
  6. Price about usual
DemandDo people want more of what it sells?growing

VTR sales growth revenue growth

+12%a year, for the last 3 years

Ventas' sales grew 12% a year for 3 years, to $5.83B in fiscal 2025.

VTR analysts' forecast revenue estimates

+20%the sales they expect next fiscal year, on the last

Analysts expect Ventas' sales to grow 20% to $6.98B in fiscal 2026 (3 analysts).

VTR peers

pretickt analysis+22%its sales in 12 months, on a year before

Ventas' sales grew 22% in the 12 months to Sep 30, 2026, faster than Realty Income (+9%), Crown Castle (-16%) and Healthpeak (-20%), slower than Welltower (+40%).

VTR sales by business revenue by segment

74%of its sales from Senior Living Operations

Senior Living Operations brought Ventas 74% of its sales in fiscal 2025; Outpatient Medical And Research Portfolio 16%.

Advantage moatIs it hard to copy?some edge

VTR margin on each sale gross margin

-1%left after making the product

Ventas kept -1% of each sale after making the product in the 12 months to Sep 30, 2026; its peers' median is 42%.

EconomicsDoes it make good money?profits growing

VTR profit per share

+193%in its last fiscal year

Ventas' earnings per share grew 193% in fiscal 2025, to $0.55.

ExecutionDoes it deliver what it promises?no reading

VTR insider selling

-$12.18Msold, net, by its executives in 12 months

Ventas' executives and directors sold a net $12.18M of shares in the 12 months to Nov 13, 2026 ($12.38M sold, $197K bought).

VTR number of employees

+9%more people in a year

Ventas had 542 employees at the end of fiscal 2025, 9% more than a year before.

VTR CEO pay

$17.5Mfor fiscal 2025, 69% of it in stock and options

Ventas paid its CEO $17.5M for fiscal 2025, 69% of it in stock and options.

Fragility risksCould something break it?sturdy

VTR financial health Altman Z-score

1.9Altman Z-score, safe above 3

Ventas' Altman Z-score is 1.9 (Nov 13, 2026), between 1.8 and 3, the grey zone.

VTR biggest customers

under 10%of sales from any one customer

No customer made 10% of Ventas' sales in fiscal 2025.

VTR in past recessions

pretickt analysis-2%its sales in the worst one

Ventas' sales fell in 1 of the last 2 US recessions, by as much as 2% in fiscal 2020.

Price valuationIs the price reasonable?about usual

VTR price vs profit P/E ratio

167.8×a year's earnings

Ventas' P/E ratio is 167.8 (Nov 13, 2026), near its 3-year median of 162.4.

VTR price vs peers

pretickt analysis167.8×a year's earnings, against its peers

Investors pay 167.8 times Ventas' earnings (Nov 13, 2026), more than for Welltower (120.4), Healthpeak (38.4) or Crown Castle (38.0).

VTR analysts' target price target

+10%to their average target

Analysts' average price target for Ventas is $97.38, 10% above the Nov 13, 2026 close of $88.92.

What is Ventas' P/E ratio?

Ventas' P/E ratio is 167.8 (Nov 13, 2026), near its 3-year median of 162.4. Investors pay 167.8 times Ventas' earnings (Nov 13, 2026), more than for Welltower (120.4), Healthpeak (38.4) or Crown Castle (38.0).

Are insiders selling Ventas stock?

Ventas' executives and directors sold a net $12.18M of shares in the 12 months to Nov 13, 2026 ($12.38M sold, $197K bought).

How does Ventas make money?

Senior Living Operations brought Ventas 74% of its sales in fiscal 2025; Outpatient Medical And Research Portfolio 16%.

How many employees does Ventas have?

Ventas had 542 employees at the end of fiscal 2025, 9% more than a year before.

Who are Ventas' biggest customers?

No customer made 10% of Ventas' sales in fiscal 2025.

From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.